188 related articles for article (PubMed ID: 32713439)
41. Radiological evaluation of response to neoadjuvant treatment in pancreatic cancer.
Cassinotto C; Sa-Cunha A; Trillaud H
Diagn Interv Imaging; 2016 Dec; 97(12):1225-1232. PubMed ID: 27692675
[TBL] [Abstract][Full Text] [Related]
42. Borderline and locally advanced pancreatic adenocarcinoma margin accentuation with intraoperative irreversible electroporation.
Kwon D; McFarland K; Velanovich V; Martin RC
Surgery; 2014 Oct; 156(4):910-20. PubMed ID: 25239345
[TBL] [Abstract][Full Text] [Related]
43. Neoadjuvant therapy for resectable pancreatic cancer.
Raut CP; Evans DB; Crane CH; Pisters PW; Wolff RA
Surg Oncol Clin N Am; 2004 Oct; 13(4):639-61, ix. PubMed ID: 15350939
[TBL] [Abstract][Full Text] [Related]
44. Borderline Resectable and Locally Advanced Pancreatic Cancers: A Review of Definitions, Diagnostics, Strategies for Treatment, and Future Directions.
Khachfe HH; Habib JR; Nassour I; Al Harthi S; Jamali FR
Pancreas; 2021 Oct; 50(9):1243-1249. PubMed ID: 34860806
[TBL] [Abstract][Full Text] [Related]
45. Neoadjuvant
Hashmi A; Kozick Z; Fluck M; Hunsinger MA; Wild J; Arora TK; Shabahang MM; Blansfield JA
Am Surg; 2018 Sep; 84(9):1439-1445. PubMed ID: 30268172
[TBL] [Abstract][Full Text] [Related]
46. Status of 5-Year Survivors of the Whipple Procedure for Pancreatic Adenocarcinoma.
Mehtsun WT; Hashimoto DA; Ferrone CR
Adv Surg; 2019 Sep; 53():253-269. PubMed ID: 31327451
[No Abstract] [Full Text] [Related]
47. Phase I/II Trial of Neoadjuvant Oregovomab-based Chemoimmunotherapy Followed by Stereotactic Body Radiotherapy and Nelfinavir For Locally Advanced Pancreatic Adenocarcinoma.
Lin C; Verma V; Lazenby A; Ly QP; Berim LD; Schwarz JK; Madiyalakan M; Nicodemus CF; Hollingsworth MA; Meza JL; Are C; Padussis J; Grem JL
Am J Clin Oncol; 2019 Oct; 42(10):755-760. PubMed ID: 31513018
[TBL] [Abstract][Full Text] [Related]
48. Does preoperative therapy optimize outcomes in patients with resectable pancreatic cancer?
Papalezova KT; Tyler DS; Blazer DG; Clary BM; Czito BG; Hurwitz HI; Uronis HE; Pappas TN; Willett CG; White RR
J Surg Oncol; 2012 Jul; 106(1):111-8. PubMed ID: 22311829
[TBL] [Abstract][Full Text] [Related]
49. [Neoadjuvant therapy vs. upfront resection for resectable pancreatic cancer].
Strobel O; Büchler MW
Chirurg; 2017 Jul; 88(7):619. PubMed ID: 28573533
[No Abstract] [Full Text] [Related]
50. Pancreatic resections after chemoradiotherapy for locally advanced ductal adenocarcinoma: analysis of perioperative outcome and survival.
Massucco P; Capussotti L; Magnino A; Sperti E; Gatti M; Muratore A; Sgotto E; Gabriele P; Aglietta M
Ann Surg Oncol; 2006 Sep; 13(9):1201-8. PubMed ID: 16955382
[TBL] [Abstract][Full Text] [Related]
51. Predictors of Resectability and Survival in Patients With Borderline and Locally Advanced Pancreatic Cancer who Underwent Neoadjuvant Treatment With FOLFIRINOX.
Michelakos T; Pergolini I; Castillo CF; Honselmann KC; Cai L; Deshpande V; Wo JY; Ryan DP; Allen JN; Blaszkowsky LS; Clark JW; Murphy JE; Nipp RD; Parikh A; Qadan M; Warshaw AL; Hong TS; Lillemoe KD; Ferrone CR
Ann Surg; 2019 Apr; 269(4):733-740. PubMed ID: 29227344
[TBL] [Abstract][Full Text] [Related]
52. Pathologic Response to Primary Systemic Therapy With FOLFIRINOX in Patients With Resectable Pancreatic Cancer.
Polish A; Joseph NE; Marsh RW
Am J Clin Oncol; 2019 Oct; 42(10):761-766. PubMed ID: 31569128
[TBL] [Abstract][Full Text] [Related]
53. Locally advanced pancreatic adenocarcinoma: reassessment of response with CT after neoadjuvant chemotherapy and radiation therapy.
Cassinotto C; Mouries A; Lafourcade JP; Terrebonne E; Belleannée G; Blanc JF; Lapuyade B; Vendrely V; Laurent C; Chiche L; Wagner T; Sa-Cunha A; Gaye D; Trillaud H; Laurent F; Montaudon M
Radiology; 2014 Oct; 273(1):108-16. PubMed ID: 24960211
[TBL] [Abstract][Full Text] [Related]
54. [A Successful Case of Locally Advanced Pancreatic Cancer Undergoing Curative Total Pancreatectomy after Chemotherapy].
Terashima T; Kawamoto S; Maekawa K; Shinozaki N; Kuroki N
Gan To Kagaku Ryoho; 2020 Apr; 47(4):688-690. PubMed ID: 32389985
[TBL] [Abstract][Full Text] [Related]
55. Complete pathological response following neoadjuvant FOLFIRINOX in borderline resectable pancreatic cancer - a case report and review.
Gostimir M; Bennett S; Moyana T; Sekhon H; Martel G
BMC Cancer; 2016 Oct; 16(1):786. PubMed ID: 27724927
[TBL] [Abstract][Full Text] [Related]
56. ASO Author Reflections: Chemotherapy Regimen in Borderline Resectable and Locally Advanced Pancreatic Cancer-Resection Cuts the Deal.
Eshmuminov D; Aminjonov B; Palm RF; Lehmann K
Ann Surg Oncol; 2023 Jul; 30(7):4429-4430. PubMed ID: 37074518
[No Abstract] [Full Text] [Related]
57. Surgery Improves Survival After Neoadjuvant Therapy for Borderline and Locally Advanced Pancreatic Cancer: A Single Institution Experience.
Rangelova E; Wefer A; Persson S; Valente R; Tanaka K; Orsini N; Segersvärd R; Arnelo U; Del Chiaro M
Ann Surg; 2021 Mar; 273(3):579-586. PubMed ID: 30946073
[TBL] [Abstract][Full Text] [Related]
58. Preoperative chemotherapy, radiotherapy, and surgical resection of locally advanced pancreatic cancer.
Wanebo HJ; Glicksman AS; Vezeridis MP; Clark J; Tibbetts L; Koness RJ; Levy A
Arch Surg; 2000 Jan; 135(1):81-7; discussion 88. PubMed ID: 10636353
[TBL] [Abstract][Full Text] [Related]
59. Defining venous involvement in borderline resectable pancreatic cancer.
Chun YS; Milestone BN; Watson JC; Cohen SJ; Burtness B; Engstrom PF; Haluszka O; Tokar JL; Hall MJ; Denlinger CS; Astsaturov I; Hoffman JP
Ann Surg Oncol; 2010 Nov; 17(11):2832-8. PubMed ID: 20725860
[TBL] [Abstract][Full Text] [Related]
60. Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines.
Tempero MA; Malafa MP; Behrman SW; Benson AB; Casper ES; Chiorean EG; Chung V; Cohen SJ; Czito B; Engebretson A; Feng M; Hawkins WG; Herman J; Hoffman JP; Ko A; Komanduri S; Koong A; Lowy AM; Ma WW; Merchant NB; Mulvihill SJ; Muscarella P; Nakakura EK; Obando J; Pitman MB; Reddy S; Sasson AR; Thayer SP; Weekes CD; Wolff RA; Wolpin BM; Burns JL; Freedman-Cass DA
J Natl Compr Canc Netw; 2014 Aug; 12(8):1083-93. PubMed ID: 25099441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
